From: Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
Characteristic | No. of patients (%) |
---|---|
Age (years) | |
Mean | 52.30 |
Range | 29.0–84.0 |
Gender | |
Male | 114 (87.7) |
Female | 16 (12.3) |
Site of primary tumor | |
Tongue | 58 (44.6) |
Mouth floor | 3 (2.3) |
Lip | 5 (3.8) |
Buccal mucosa | 44 (33.8) |
Alveolar ridge | 13 (10.0) |
Hard palate | 0 (0) |
Retromolar trigone | 7 (5.4) |
Pathologic tumor status | |
T1 | 36 (27.7) |
T2 | 38 (29.2) |
T3 | 13 (10.0) |
T4a | 30 (23.1) |
T4b | 13 (10.0) |
Pathologic N stage | |
N0 | 68 (52.3) |
N1 | 25 (19.2) |
N2b | 30 (23.1) |
N2c | 7 (5.4) |
Pathologic stage | |
Stage I | 28 (21.5) |
Stage II | 17 (13.1) |
Stage III | 23 (17.7) |
Stage IV | 62 (47.7) |
Treatment | |
Surgery alone | 57 (43.8) |
Surgery with adjuvant radiation therapy | 12 (9.2) |
Surgery with adjuvant chemoradiation therapy | 58 (44.6) |
Chemoradiation therapy plus surgery | 3 (2.3) |